Companies developing drugs for the central nervous system have few tools for determining whether a drug is effective, beyond observing the behavior of large numbers of patients. Miicro Inc. believes that brain metabolism may reveal clues about a drug's effect on the brain. Its method combines PET scans of F-18 in the brain with standardized procedures for behavioral control of subjects, data collection, data processing and analysis.